Skip to main content
Rase AI Intelligence Newsletter

Healthcare, biotechnology & medical AI Product

VUNO Med-DeepBrain measures structures on brain MRI

VUNO Med-DeepBrain automatically labels and quantifies structures visible on brain MRI and displays the results for professional review. [1]

Release status
U.S. FDA 510(k) clearance K231398, decided October 4, 2023. [1]

What it does

The FDA cleared the named software on October 4, 2023, under 510(k) K231398 as a Class II medical image management and processing system. [1]

Why it matters

The software automates the production of structural measurements that would otherwise require manual identification and labeling. [1]

Who it’s for

The published use concerns healthcare professionals who review structural brain MRI. [1]

Key dates

  1. FDA clears VUNO Med-DeepBrain [1]

Where it fits

The output combines labels and quantitative information with visualizations of the structures it can segment. [1]

Limits and trade-offs

The FDA filing describes an image-processing function and its defined outputs. It does not establish a disease-specific diagnosis claim. [1]

Sources and verification

Catalog evidence checked How we verify records

  1. Primary source FDA 510(k) decision for VUNO Med-DeepBrain (K231398)

Related profiles

Healthcare, biotechnology & medical AI

Sleep Analysis Module (SAM)

Neurotronics (Nihon Kohden)

The module estimates sleep time from a signal captured during its intended sleep-testing workflow.

High confidenceEvidence checked

Healthcare, biotechnology & medical AI

Heartvue.Proton

Heartvue.ai

It is software for analyzing cardiac MRI images within its documented intended-use scope.

Medium confidenceEvidence checked

Healthcare, biotechnology & medical AI

ThinkSono Guidance

ThinkSono

Provides guidance during acquisition of lower-extremity compression ultrasound images for review by healthcare professionals.

High confidenceEvidence checked